These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 21157106

  • 21. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 22. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H, PRECISE–IVUS Investigators.
    J Am Coll Cardiol; 2015 Aug 04; 66(5):495-507. PubMed ID: 26227186
    [Abstract] [Full Text] [Related]

  • 23. Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
    Kurtoglu E, Balta S, Sincer I, Altas Y, Atas H, Yilmaz M, Korkmaz H, Erdem K, Akturk E, Demirkol S, Can C.
    Angiology; 2014 Oct 04; 65(9):788-93. PubMed ID: 24163120
    [Abstract] [Full Text] [Related]

  • 24. Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).
    Nicholls SJ, Borgman M, Nissen SE, Raichlen JS, Ballantyne C, Barter P, Chapman MJ, Erbel R, Libby P.
    Curr Med Res Opin; 2011 Jun 04; 27(6):1119-29. PubMed ID: 21446892
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia.
    Bays HE, Averna M, Majul C, Muller-Wieland D, De Pellegrin A, Giezek H, Lee R, Lowe RS, Brudi P, Triscari J, Farnier M.
    Am J Cardiol; 2013 Dec 15; 112(12):1885-95. PubMed ID: 24063830
    [Abstract] [Full Text] [Related]

  • 26. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
    Brener SJ, Ivanc TB, Hu T.
    J Invasive Cardiol; 2008 Jun 15; 20(6):261-5. PubMed ID: 18523316
    [Abstract] [Full Text] [Related]

  • 27. Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.
    Saku K, Zhang B, Noda K, PATROL Trial Investigators.
    Circ J; 2011 Jun 15; 75(6):1493-505. PubMed ID: 21498906
    [Abstract] [Full Text] [Related]

  • 28. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
    Davidson M, Ma P, Stein EA, Gotto AM, Raza A, Chitra R, Hutchinson H.
    Am J Cardiol; 2002 Feb 01; 89(3):268-75. PubMed ID: 11809427
    [Abstract] [Full Text] [Related]

  • 29. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
    Puri R, Nissen SE, Shao M, Uno K, Kataoka Y, Kapadia SR, Tuzcu EM, Nicholls SJ.
    Am J Cardiol; 2014 Nov 15; 114(10):1465-72. PubMed ID: 25282317
    [Abstract] [Full Text] [Related]

  • 30. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN, REVERSAL Investigators.
    JAMA; 2004 Mar 03; 291(9):1071-80. PubMed ID: 14996776
    [Abstract] [Full Text] [Related]

  • 31. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
    Rader DJ, Davidson MH, Caplan RJ, Pears JS.
    Am J Cardiol; 2003 Mar 06; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
    [Abstract] [Full Text] [Related]

  • 32. Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia.
    Stein EA, Strutt K, Southworth H, Diggle PJ, Miller E, HeFH Study Group.
    Am J Cardiol; 2003 Dec 01; 92(11):1287-93. PubMed ID: 14636905
    [Abstract] [Full Text] [Related]

  • 33. Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.
    Qu HY, Xiao YW, Jiang GH, Wang ZY, Zhang Y, Zhang M.
    Pharm Res; 2009 Apr 01; 26(4):958-64. PubMed ID: 19082693
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
    Wakabayashi K, Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Miyake S, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Suzuki H, Michishita I, TRUTH investigators.
    J Atheroscler Thromb; 2016 Sep 01; 23(9):1055-66. PubMed ID: 27040362
    [Abstract] [Full Text] [Related]

  • 35. [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].
    Kuznetsova MA, Vaulin NA, Masenko VP, Gratsianskiĭ NA.
    Kardiologiia; 2010 Sep 01; 50(2):21-5. PubMed ID: 20146674
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.
    Am Heart J; 2004 Jul 01; 148(1):e4. PubMed ID: 15215813
    [Abstract] [Full Text] [Related]

  • 37. Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.
    Park JS, Kim YJ, Choi JY, Kim YN, Hong TJ, Kim DS, Kim KY, Jeong MH, Chae JK, Oh SK, Seong IW.
    Korean J Intern Med; 2010 Mar 01; 25(1):27-35. PubMed ID: 20195400
    [Abstract] [Full Text] [Related]

  • 38. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 39. Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
    Insull W, Ghali JK, Hassman DR, Y As JW, Gandhi SK, Miller E, SOLAR Study Group.
    Mayo Clin Proc; 2007 May 01; 82(5):543-50. PubMed ID: 17493418
    [Abstract] [Full Text] [Related]

  • 40. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW, Liem AH, Dunselman PH, van der Sloot JA, Lok DJ, Zwinderman AH.
    Curr Med Res Opin; 2005 Nov 01; 21(11):1865-74. PubMed ID: 16307708
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.